Related Experiment Videos
[Prognostic factors in low-grade lymphoma]
M A Gandarillas1, E Conde, F Mazorra
1Servicio de Hematología y Hemoterapia, Hospital Universitario Marqués de Valdecilla, Santander.
Sangre
|September 19, 1998
Summary
Large tumor burden is the most significant prognostic factor in low-grade non-Hodgkin
Area of Science:
- Hematology
- Oncology
- Clinical Research
Context:
- Prognostic factors for low-grade non-Hodgkin's lymphoma (LGL) remain incompletely defined.
- Understanding these factors is crucial for optimizing treatment strategies and patient outcomes.
- This study retrospectively analyzes LGL cases treated over a decade.
Purpose:
- To identify and validate key prognostic factors in patients with low-grade non-Hodgkin's lymphoma.
- To evaluate the impact of clinical variables and treatment response on survival and complete response rates.
Summary:
- Seventy newly diagnosed LGL cases were analyzed, with a median follow-up of 37 months.
- Large tumor burden and B symptoms were identified as significant predictors of poor complete response.
- Large tumor burden emerged as the most critical prognostic variable for overall survival, independent of treatment response.
Impact:
- This research highlights large tumor burden as a primary determinant of prognosis in LGL.
- Findings may inform risk stratification and personalized treatment approaches for LGL patients.
- The study underscores the importance of assessing tumor burden for predicting outcomes in low-grade lymphomas.